Evidence map›Paper›PMID 7477417›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology1995

Classification of alpha 1-adrenoceptor subtypes.

M C Michel, B Kenny, D A Schwinn

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Functional characterization of the αFrontiers in pharmacology · 2025
    Article
  7. 17β-Estradiol Concentration and Direct βAnnals of neurosciences · 2022
    Article
  8. Article
  9. Review
  10. The α1-adrenergic receptors: diversity of signaling networks and regulation.Journal of receptor and signal transduction research · 2010
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

M C MichelDepartment of Medicine, University of Essen, Germany.
B Kenny
D A Schwinn
Duke University · USPfizer (United Kingdom) · GBUniversity of Duisburg-Essen · DE

Funding

Subcellular Distribution &Regulation of ala-AdrenoceptoR37HL049103 · NHLBI · UNIVERSITY OF WASHINGTON · PI SCHWINN, DEBRA ANNE · 2005 to 2014
$3.9M
MOLECULAR DISTRIBUTION OF HUMAN ADRENERGIC RECEPTORSR01HL049103 · NHLBI · DUKE UNIVERSITY · PI SCHWINN, DEBRA A. · 1993 to 2003
$1.4M
MOLECULAR CHARACTERIZATION--ALPHA 1-ADRENERGIC RECEPTORK08HL002490 · NHLBI · DUKE UNIVERSITY · PI SCHWINN, DEBRA A. · 1990 to 1994
–
NHLBI NIH HHS HL 02490NHLBI NIH HHS HL49103
6 · The paper itself

Abstract

Two alpha 1-adrenoceptor subtypes (alpha 1A and alpha 1B) have been detected in various tissues by pharmacological techniques, and three distinct cDNAs encoding alpha 1-adrenoceptor subtypes have been cloned. The profile of an increasing number of subtype-selective compounds at cloned and endogenous receptors recently has facilitated alignment between cloned and pharmacologically defined alpha 1-adrenoceptor subtypes. Thus, alpha 1a-adrenoceptors (previously designated alpha 1c), alpha 1b-adrenoceptors and alpha 1d-adrenoceptors (previously designated alpha 1a, alpha 1d or alpha 1a/d) are now recognized. Since the alpha 1d-adrenoceptor shares characteristics with both alpha 1A- and alpha 1B-adrenoceptors, tissues previously reported to express alpha 1A- and/or alpha 1B-adrenoceptors may additionally contain alpha 1d-adrenoceptors. This article reviews the features of all three subtypes and discusses possible pitfalls in their pharmacological identification.

Indexed as

AnimalsBinding, CompetitiveDNA, ComplementaryMethoxaminePhentolamineReceptors, Adrenergic, alpha-1Terminology as TopicDNA, ComplementaryMethoxaminePhentolamineReceptors, Adrenergic, alpha-1

Identifiers

PMID7477417
OpenAlexW2035986648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.